Michael Weiser - Net Worth and Insider Trading
Michael Weiser Net Worth
The estimated net worth of Michael Weiser is at least $1 Million dollars as of 2024-06-06. Michael Weiser is the Director of Iovance Biotherapeutics Inc and owns about 141,116 shares of Iovance Biotherapeutics Inc (IOVA) stock worth over $1 Million. Michael Weiser is also the Director of Alaunos Therapeutics Inc and owns about 9,063 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $9,788. Details can be seen in Michael Weiser's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Weiser has not made any transactions after 2022-05-31 and currently still holds the listed stock(s).
Transaction Summary of Michael Weiser
Michael Weiser Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Weiser owns 5 companies in total, including Iovance Biotherapeutics Inc (IOVA) , Alaunos Therapeutics Inc (TCRT) , and Emisphere Technologies Inc (EMIS) among others .
Click here to see the complete history of Michael Weiser’s form 4 insider trades.
Insider Ownership Summary of Michael Weiser
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2022-05-31 | director |
| TCRT | Alaunos Therapeutics Inc | 2011-05-25 | director |
| EMIS | Emisphere Technologies Inc | 2017-05-18 | director |
 | | 2010-03-03 | other: Former Director |
| | 2008-06-13 | director |
Michael Weiser Latest Holdings Summary
Michael Weiser currently owns a total of 2 stocks. Among these stocks, Michael Weiser owns 141,116 shares of Iovance Biotherapeutics Inc (IOVA) as of May 31, 2022, with a value of $1 Million and a weighting of 99.15%. Michael Weiser also owns 9,063 shares of Alaunos Therapeutics Inc (TCRT) as of May 25, 2011, with a value of $9,788 and a weighting of 0.85%.
Latest Holdings of Michael Weiser
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2022-05-31 | 141,116 | 8.14 | 1,147,979 |
| TCRT | Alaunos Therapeutics Inc | 2011-05-25 | 9,063 | 1.08 | 9,788 |
Holding Weightings of Michael Weiser
Michael Weiser Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Weiser has made a total of 1 transactions in Iovance Biotherapeutics Inc (IOVA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Iovance Biotherapeutics Inc is the acquisition of 10,000 shares on May 31, 2022, which cost Michael Weiser around $68,000.
According to the SEC Form 4 filings, Michael Weiser has made a total of 0 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years. The most-recent trade in Alaunos Therapeutics Inc is the sale of 1,000 shares on May 25, 2011, which brought Michael Weiser around $97,950.
Insider Trading History of Michael Weiser
- 1
Michael Weiser Trading Performance
GuruFocus tracks the stock performance after each of Michael Weiser's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Weiser is 58.81%. GuruFocus also compares Michael Weiser's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Weiser within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Weiser's insider trading performs compared to the benchmark.
Performance of Michael Weiser
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 69.93 | | | | | |
| Relative Return to S&P 500(%) | 77.36 | | | | | |
Michael Weiser Ownership Network
Michael Weiser Owned Company Details
What does Iovance Biotherapeutics Inc do?
Who are the key executives at Iovance Biotherapeutics Inc?
Michael Weiser is the director of Iovance Biotherapeutics Inc. Other key executives at Iovance Biotherapeutics Inc include General Counsel Frederick G Vogt , Chief Operating Officer Igor Bilinsky , and Chief Financial Officer Jean-marc Bellemin .
Iovance Biotherapeutics Inc (IOVA) Insider Trades Summary
Over the past 18 months, Michael Weiser made no insider transaction in Iovance Biotherapeutics Inc (IOVA). Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchase of 270,000 shares made by Merrill A Mcpeak , and a net purchase of 10,000,000 shares made by Wayne P. Rothbaum .
In summary, during the past 3 months, insiders sold 0 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 10,270,000 shares were bought by its insiders, resulting in a net purchase of 10,270,000 shares.
Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iovance Biotherapeutics Inc Insider Transactions
Michael Weiser Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Weiser. You might contact Michael Weiser via mailing address: C/o Spaces, Suite 265, 3350 Virginia Street, Miami Fl 33133.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
